ÂÜŔňÂŇÂ×

Alph Bingham, Ph.D., joined MicroMGx as a Science/Industry Advisor in March of 2021. He is co-founder and former President and Chairman of InnoCentive, Inc. He has been a strong advocate of open innovation and founded InnoCentive along with other ventures that create the advantages of open and networked organizational structures, including: YourEncore, Inc., Coalesix, Inc., Maaguzi, Inc., Indigo Biosystems, Seriosity, Chorus and Collaborative Drug Discovery, Inc. He also remains active as Founder and CEO of Cascade Consulting through which he has worked with numerous biotechs and startups advising in the areas of portfolio management, computational modeling and open innovation systems.

Dr. Bingham currently serves on the Board of Directors of Collaborative Drug Discovery, Inc. and the advisory boards of the Center for Collective Intelligence (MIT) and recently Elanco Animal Health. He has lectured extensively at both national and international events and has served as a Visiting Scholar at the National Center for Supercomputing Application at the University of Illinois at Champaign-Urbana. Dr. Bingham is also the former chairman of the Board of Editors of the Research Technology Management Journal. He was the recipient of the Economist’s Fourth Annual Innovation Summit “Business Process Award” for InnoCentive. He was also named as one of Project Management Institute’s “Power 50” leaders in October 2005.

Dr. Bingham had over 25 years of experience with Eli Lilly and Company in pharmaceutical research and development, research acquisitions and collaborations, portfolio management and R&D strategic planning. Among others, he held positions as Managing Director of the Mont-Saint-Guibert Development Centre, executive director of project and portfolio management, vice-president of sourcing innovation, vice-president of e.Lilly and vice-president of R&D strategy. During his career, he was instrumental in creating and developing Eli Lilly’s portfolio management process as well as establishing the divisions of Research Acquisitions, the Office of Alliance Management and e.Lilly, a unit for business innovation.

Dr. Bingham has authored and co-authored numerous articles published in journals such as Harvard Business Review and the MIT Sloan Management Review. In April 2011, he co-authored with Dwayne Spradlin, the book, “The Open Innovation Marketplace.” In 2020, he co-authored with Simon Hill a second book, “One Smart Crowd.” He received a Ph.D. in organic chemistry from Stanford University.